Facing Alzheimer’s Disease Early is the Best Policy

October 21st, 2006

Often, a person with symptoms of early Alzheimer’s disease is reluctant to get medical care, for fear of being labeled “crazy” or incompetent. A recent survey found that 57% delayed seeking a formal diagnosis for 2 to 3 1/2 years after onset of their symptoms.

Delay in seeking help is counterproductive and unnecessary, as the disease becomes harder to treat in more advanced stages. In addition, not knowing for certain can cause heightened anxiety and in patients and their caregivers.

Alzheimer’s progresses at different rates in individuals, but the patient may live with the condition for 8 to 20 years. Early diagnosis and treatment is believed to slow its progression and alleviate much of the stress of the patient and family members. In addition, early recognition gives time to put one’s affairs in order. Wills, durable powers of attorney, financial matters, and treatment preferences are better dealt with early in the disease.

Structured activities such as participation in psychotherapy groups, painting classes or musical activities can help patients live more fully after diagnosis. Despite cognitive decline, some Alzheimer’s patients show amazing ability to express themselves in art or musical performance. Support through group therapy also helps many patients bolster their self-image and accept their disease with grace.

As for medical treatments, three cholinesterase inhibitors are -approved and available to treat Alzheimer’s. Razadyne and Aricept are thought to delay mental decline and symptoms in those with mild to moderate Alzheimer’s. Namenda is approved for treatment of later stages of the disease.

Facing the diagnosis early helps patients and caregivers to challenge the stigma of Alzheimer’s by seeking proper care in timely fashion.
Source:  Johns Hopkins Health After 50 Medical Newsletter, August 2006

Tags: , ,

Entry Filed under: Alzheimer's

Leave a Comment

You must be logged in to post a comment.

Trackback this post  |  Subscribe to the comments via RSS Feed


Most Recent Articles

Sponsored Links